Legal & General Group’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,902
Closed -$107K 3702
2022
Q1
$107K Sell
6,902
-195
-3% -$3.38K ﹤0.01% 2847
2021
Q4
$189K Buy
7,097
+5,924
+505% +$225K ﹤0.01% 2743
2021
Q3
$57K Buy
1,173
+663
+130% +$41K ﹤0.01% 2948
2021
Q2
$43K Sell
510
-117
-19% -$10.1K ﹤0.01% 3001
2021
Q1
$63K Sell
627
-2,314
-79% -$254K ﹤0.01% 2754
2020
Q4
$296K Buy
2,941
+2,323
+376% +$155K ﹤0.01% 2348
2020
Q3
$29K Buy
618
+104
+20% +$5.34K ﹤0.01% 2862
2020
Q2
$30K Buy
+514
New +$34.3K ﹤0.01% 2900

Other funds holding AWH

Legal & General Group's AWH Position: Q2 2022 in Review

Legal & General Group sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q2 2022, closing a stake of 6,902 shares — an estimated $107K sold.

Legal & General Group first reported a position in AWH in Q2 2020 and held it in 8 quarters. The position peaked at $296K in Q4 2020. 72 funds tracked by Wall St. Rank hold AWH as of Q2 2022.

  • Legal & General Group reported no remaining Aspira Women's Health Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 6,902 Aspira Women's Health Inc. Common Stock shares in Q2 2022, an estimated $107K.
  • Legal & General Group first reported a position in Aspira Women's Health Inc. Common Stock in Q2 2020 and held it in 8 quarters.
  • Legal & General Group's Aspira Women's Health Inc. Common Stock position peaked at $296K in Q4 2020.
  • 72 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.